Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) saw a large decline in short interest during the month of June. As of June 15th, there was short interest totaling 1,880 shares, a decline of 93.9% from the May 31st total of 30,585 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 124,355 shares, the days-to-cover ratio is currently 0.0 days.
Analysts Set New Price Targets
Several equities analysts recently commented on SAUHY shares. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a research note on Tuesday, April 14th. Barclays reaffirmed an “overweight” rating on shares of Straumann in a research note on Thursday, June 18th. Finally, Citigroup reiterated a “sell” rating on shares of Straumann in a report on Thursday, April 23rd. Two investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold”.
Get Our Latest Report on SAUHY
Straumann Stock Performance
About Straumann
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
Featured Articles
- Five stocks we like better than Straumann
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
